Prevention of venous pain and phlebitis caused by epirubicin hydrochloride

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 6, 2009, Pages 969-974

  Sugimoto, Masakazu ^a   Matsui, Masateru ^a   Harada, Masanori ^a   Yamauchi, Yumiko ^a   Moriyama, Nao ^a   Andou, Kanae ^a   Yamamoto, Makoto ^a   Yamaoka, Hisayo ^b   Ono, Chiemi ^a   Ishikawa, Mami ^a   Kamo, Nobuyuki ^a   Ikeda, Tadashi ^a   Yamaoka, Keiko ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Epirubicin hydrochloride; Main route; Phlebitis; Sub route; Venous pain; VIP score

Indexed keywords

EPIRUBICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; INFUSION; INTIMA; LONG TERM EXPOSURE; PHLEBITIS; PREMEDICATION; STIMULATION; VEIN PAIN; VOMITING;

EID: 79959815409     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Nakazawa Y, Matsubara Y, Suzuki M, et al: Vasculitic Condition Following Instillation of Epirubicin Hydrochloride in an Outpatient Chemotherapy. Jpn J Cancer Chemother 32 (Suppl I): 24-26, 2005.
2. Yamaoka K, Matsui M and Kaga A: Analysis of adriamycin, pirarubicin, epirubicin, and their metabolites in plasma, blood cell and urine. J Pharm Sci Technol Jpn 52: 186-192, 1992.
3. Dogherty L: Standards for infusion therapy, RCN IV Therapy Forum 2003. Royal College of Nursing, 2004.
4. Kakuta T: Injection manual for nurses and doctors. The 2nd edition, Nankodo, Tokyo, Japan, 2000, pp102-103.
5. Maki D. G and Ringer M: Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine 114: 845-854, 1991.
6. Okamura K, Nagamoto N, Kume S, et al: The effect of pH and titrable acidity of infusion on thrombophlebitis during peripheral parenteral nutrition. Jpn J Surg Metab Nutr (JJSMN) 32: 303-308, 1998.
7. Masuda S, Anami S, Ishitobi M, et al: The device for supportive care in FEC (fluorouracil, epirubicin hydrochloride, cyclophosphamide) therapy: Prevention of venous pain and phlebitis. The Medical Oncologists 1 (4): 55-62, 2005.
8. Nippon Kayaku Co., Ltd. Interview Form of Epirubicin "Merck", The 4th edition, 2007, pp32
9. Ikeda H and Koshiba R: Comparison of prior administration of Granisetoron with simultaneous administration of Cisplatin. Jpn J Cancer Chemother 25(12): 1947-1953, 1998.
10. Anami S, Masuda N, Nishikata M, et al: Factors Associated with Phlebitis and Venous Pain due to Intravenous Injection of Epirubicin Hydrochloride. Jpn J Pharm Health Care Sci 32(11): 1105-1110, 2006.